Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lisziewicz

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Gene Therapy|March 1, 2000
Inhibition of HIV-1 replication in chronically infected cell lines and peripheral blood mononuclear cells by retrovirus-mediated antitat gene transferY Li, S E Starr, J Lisziewicz, et al.
Human Gene Therapy|December 1, 1996
Efficacy of antitat gene therapy in the presence of high multiplicity infection and inflammatory cytokinesJ Lisziewicz, D Sun, R C Gallo, et al.
Human Gene Therapy|April 25, 2000
Combination gene therapy: synergistic inhibition of human immunodeficiency virus Tat and Rev functions by a single RNA moleculeJ Lisziewicz, G Zeng, C Gratas, et al.
Journal of Neurochemistry|January 1, 1985
Separation of recycling and reserve synaptic vesicles from cholinergic nerve terminals of the myenteric plexus of guinea pig ileumD V Agoston, J W Kosh, J Lisziewicz, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 30, 1999
Hydroxyurea toxicity combined with didanosine (ddl) in HIV-1-seropositive asymptomatic individualsE Seminari, J Lisziewicz, C Tinelli, et al.
Lancet (London, England)|February 16, 2000
Structured treatment interruptions to control HIV-1 infectionF Lori, R Maserati, A Foli, et al.
Gene Therapy|May 1, 1994
Block of HIV-1 infection by a combination of antisense tat RNA and TAR decoys: a strategy for control of HIV-1H K Chang, R Gendelman, J Lisziewicz, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1992
Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatmentJ Lisziewicz, D Sun, M Klotman, et al.
AIDS Research and Human Retroviruses|May 20, 1999
Immune restoration by combination of a cytostatic drug (hydroxyurea) and anti-HIV drugs (didanosine and indinavir)F Lori, H Jessen, J Lieberman, et al.
Antiviral Therapy|January 1, 1997
Hydroxyurea and didanosine is a more potent combination than hydroxyurea and zidovudineA Foli, F Lori, R Maserati, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Gene Therapy|March 1, 2000
Inhibition of HIV-1 replication in chronically infected cell lines and peripheral blood mononuclear cells by retrovirus-mediated antitat gene transferY Li, S E Starr, J Lisziewicz, et al.
Human Gene Therapy|December 1, 1996
Efficacy of antitat gene therapy in the presence of high multiplicity infection and inflammatory cytokinesJ Lisziewicz, D Sun, R C Gallo, et al.
Human Gene Therapy|April 25, 2000
Combination gene therapy: synergistic inhibition of human immunodeficiency virus Tat and Rev functions by a single RNA moleculeJ Lisziewicz, G Zeng, C Gratas, et al.
Journal of Neurochemistry|January 1, 1985
Separation of recycling and reserve synaptic vesicles from cholinergic nerve terminals of the myenteric plexus of guinea pig ileumD V Agoston, J W Kosh, J Lisziewicz, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 30, 1999
Hydroxyurea toxicity combined with didanosine (ddl) in HIV-1-seropositive asymptomatic individualsE Seminari, J Lisziewicz, C Tinelli, et al.
Lancet (London, England)|February 16, 2000
Structured treatment interruptions to control HIV-1 infectionF Lori, R Maserati, A Foli, et al.
Gene Therapy|May 1, 1994
Block of HIV-1 infection by a combination of antisense tat RNA and TAR decoys: a strategy for control of HIV-1H K Chang, R Gendelman, J Lisziewicz, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1992
Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatmentJ Lisziewicz, D Sun, M Klotman, et al.
AIDS Research and Human Retroviruses|May 20, 1999
Immune restoration by combination of a cytostatic drug (hydroxyurea) and anti-HIV drugs (didanosine and indinavir)F Lori, H Jessen, J Lieberman, et al.
Antiviral Therapy|January 1, 1997
Hydroxyurea and didanosine is a more potent combination than hydroxyurea and zidovudineA Foli, F Lori, R Maserati, et al.
Pageof 6